What's Going On With Novavax Shares Tuesday?

Benzinga2022-04-06

Novavax Inc shares are trading significantly lower Tuesday.

According to data from Benzinga Pro, Tuesday's trading volume is in line with Novavax's average trading volume over a 100-day period.

The stock is trending across social media platforms. It was among the most mentioned tickers on Stocktwits at publication time.

Novavax may be trading lower in sympathy with Moderna Inc after the African Union and COVAX Consortium declined to purchase additional COVID-19 vaccine doses from the company.

Novavax is a biotechnology firm that specializes in vaccine development. The company is in the clinical stage of development, with the goal of developing unique treatments that prevent a variety of diseases.

NVAX 52-Week Range:$122.01 - $497.49

The stock closed lower 13.4% at $65.23 on Tuesday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • Kaineteo
    2022-04-06
    Kaineteo
    Seems a deliberate act of FDA. Never expect that coming from US
  • Jerrya
    2022-04-06
    Jerrya
    Hmm food for thought
  • LuckyPiggie
    2022-04-06
    LuckyPiggie
    Novavax needs to take some Anti Stockprice down vaccine ... [Facepalm] 
  • 小熊家族
    2022-04-06
    小熊家族
    like pls 
  • Joru
    2022-04-06
    Joru
    Ok
  • Pixiu88
    2022-04-06
    Pixiu88
    Need US FDA approval asap!
Leave a comment
15